Mylan Plaintiffs Make New Bid For Treble Damages
In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court...To view the full article, register now.
Already a subscriber? Click here to view full article